XNASWORX
Market cap2mUSD
Dec 24, Last price
1.58USD
1D
-3.07%
1Q
32.77%
Jan 2017
-55.18%
IPO
-15.73%
Name
Scworx Corp
Chart & Performance
P/E
—
P/S
0.77
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
80.27%
Rev. gr., 5y
90.90%
Revenues
4m
-5.78%
Net income
-4m
L+153.86%
CFO
-806k
L+47.47%
Profile
SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion and automation; EMR management; CDM management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company operates an online event ticketing platform focused on serving regional mixed martial arts. In addition, it offers CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 3,805 -5.78% | 4,038 -12.83% | 4,633 -11.14% | ||||||
Cost of revenue | 5,256 | 6,165 | 8,447 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | (1,451) | (2,127) | (3,814) | ||||||
NOPBT Margin | |||||||||
Operating Taxes | (279) | 2 | |||||||
Tax Rate | |||||||||
NOPAT | (1,451) | (1,847) | (3,814) | ||||||
Net income | (3,981) 153.86% | (1,568) -58.89% | (3,814) -48.47% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 573 | 725 | 525 | ||||||
BB yield | -30.15% | -15.30% | -3.87% | ||||||
| Debt | |||||||||
Debt current | 125 | 100 | |||||||
Long-term debt | 90 | 148 | 434 | ||||||
Deferred revenue | |||||||||
Other long-term liabilities | (148) | (434) | |||||||
Net debt | (1) | 23 | 462 | ||||||
| Cash flow | |||||||||
Cash from operating activities | (806) | (547) | (1,070) | ||||||
CAPEX | |||||||||
Cash from investing activities | 165 | ||||||||
Cash from financing activities | 483 | 725 | 765 | ||||||
FCF | (869) | (1,958) | (4,338) | ||||||
| Balance | |||||||||
Cash | 91 | 249 | 71 | ||||||
Long term investments | |||||||||
Excess cash | 48 | ||||||||
Stockholders' equity | (29,839) | (25,246) | (23,400) | ||||||
Invested Capital | 33,782 | 32,295 | 30,339 | ||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 1,033 | 798 | 701 | ||||||
Price | 1.84 -69.02% | 5.94 -69.30% | 19.35 -4.45% | ||||||
Market cap | 1,900 -59.91% | 4,739 -65.04% | 13,556 10.86% | ||||||
EV | 1,899 | 4,763 | 14,018 | ||||||
EBITDA | (1,451) | (2,127) | (3,738) | ||||||
EV/EBITDA | |||||||||
Interest | 6 | 279 | |||||||
Interest/NOPBT | |||||||||